Ground-Breaking Web Platform Revolutionizes Biomedical Research

Toronto, July 6, 2010 (ots/PRNewswire) - BioHub Inc., announced today
the launch of BioHub-Online.org, a first-of- its-kind online platform
to facilitate global networking and collaboration among research
scientists.

Antibodies are biomedical research reagents used for hundreds of
thousands of experiments globally. The global market for research
antibodies exceeds $2 billion, yet independent studies show that less
than 50% of commercial antibodies are of adequate quality, leading
to compromised results and wasted time and resources. Developed to
respond to this problem, BioHub-Online.org is a web-based networking
tool that not only serves as a comprehensive listing of over 100,000
antibody products, but also provides researchers with the
opportunity to provide product reviews. Taken together,
BioHub-Online.org will allow scientists to make informed decisions,
thus increasing the efficiency of biomedical research.

Motivated to advocate product excellence and transparency within
the biomedical marketplace, Alex Hodgson, co-founder of BioHub
remarked, "We as a community need to support those companies who go
that extra mile to bring us top-quality products and hold those that
don't accountable."

BioHub-Online.org has already won the support of leading
researchers, including Dr. Aled Edwards (Structural Genomics
Consortium), Dr. Sachdev Sidhu (University of Toronto), Dr. Brian
Marsden (University of Oxford) and Dr. Lori Frappier (Canada
Research Chair in Virology). "Antibodies are among the most commonly
used reagents in biomedicine, yet are subjected to the least
effective quality control. BioHub will create order from this chaos
by empowering the scientific community to communicate their reviews
of commercial products," says Dr. Aled Edwards.

BioHub promises to not only create a channel of direct feedback
between scientists and antibody providers, but also creates
opportunities for users to connect with each other. Two of BioHub's
community features include: BioAlerts, which lets users know when
new antibodies and data have been uploaded for specific targets,
while BioMessenger enables users to send direct messages to other
users to facilitate follow-on collaborations.

About BioHub, Inc.

BioHub, Inc. is a privately owned Canadian corporation that
operates BioHub-Online.org, an open-access online platform designed
to meet the needs of the biomedical research community. BioHub
enables users to connect with colleagues, discover which products
work best for specific applications, share experiences and
collaborate online.

For additional information on BioHub-Online.org, contact Alex
Hodgson (+1-647-981-2461/alex@biohub-online.org) or visit
http://www.biohub-online.org.

For further information: Alexandra Hodgson, 117-112 College
Street, Toronto, ON, Canada, M5G 1L6, Email: alex@biohub-online.org,
Tel: +1-647-981-2461

ots Originaltext: BioHub, Inc.
Im Internet recherchierbar: http://www.presseportal.de

Contact:
CONTACT: For further information: Alexandra Hodgson, 117-112
CollegeStreet, Toronto, ON, Canada, M5G 1L6, Email:
alex@biohub-online.org, Tel:+1-647-981-2461